ALEXANDRIA BURRINGO: Open Payments
NPI 1356817423 · TOOELE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$850 in 46 payments from 17 companies in 2025. Trend: 2023 $1,379 · 2024 $1,731 · 2025 $850
Food & beverage: $850
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $289 |
| Otsuka America Pharmaceutical, Inc. | 5 | $88 |
| Alkermes, Inc. | 3 | $68 |
| Indivior Inc. | 3 | $64 |
| PFIZER INC. | 3 | $43 |
| Novo Nordisk Inc | 2 | $38 |
| Lilly USA, LLC | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $29 |
Products named: VRAYLAR, REXULTI, ARISTADA, SUBLOCADE, Wegovy, MOUNJARO, NURTEC ODT, CAPLYTA.
Industry payments across UT — which companies pay providers there.
